# Dr. Florian Kainzinger

> Dr. Florian Kainzinger is a Series B investor at Think.Health backing Medical and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Think.Health](https://shizune.co/investors/profile/think-health)
- Location: Berlin, Germany
- Total investments: 2
- Last investment: Aug 2024
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/floriankainzinger/

Dr. Florian Kainzinger is a Series B investor at Think.Health in Berlin focused on Medical and Health Care. Florian Kainzinger has more than 14 years of experience in health care management positions. He was Chief Executive Officer (CEO) of Labor Berlin between 2011 and 2015 with responsibility for more than 500 employees on 12 sites in Berlin. Prior to joining the lab organization of Charité and Vivantes, Florian used to work for Roland Berger StrategyConsultants, serving hospitals and pharmaceutical clients in Germany and Europe.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series C | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sphingotec GmbH | SphingoTec is a biomaker company that develops and markets in vitro diagnostic solutions for novel and proprietary blood-based protein biomarkers. They also develop microtiter plates, which are a standard tool in analytical research and diagnostic testing laboratories. They develop biomakers to address diagnostically underserved critical careconditions such as acute kidney injury, sepsis, and acute heart failure. | $5.5M | Series C | Aug 08, 2024 |  |
| SpinDiag | Spindiag provides an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable detection of pathogens. It's first product is an automated SARS-CoV-2 test. Spindiag one can be operated with an easy to use and routine-compatible workflow by a nurse. Test results are directly transferred into the patient record.The patented centrifugal-microfluidic test system rapidly provides laboratory-grade PCR results directly from standard patient swab samples. SpinDiag works with your standard Copan ESwab® and allows culture confirmation or other lab tests without the necessity to take a second sample. The complete workflow is fully automated and suitable for operation by ward nurses. It features an ultrafast and highly-sensitive polymerase chain reaction (PCR). | $17.9M | Series B | May 26, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [Brandenburg Kapital](https://shizune.co/investors/profile/bfb-brandenburg-kapital-gmbh) — VC Fund, 1 deal together
- [HBM Healthcare Investments](https://shizune.co/investors/profile/hbm-healthcare-investments-ag) — VC Fund, 1 deal together
- [NRW.BANK](https://shizune.co/investors/profile/nrw-bank) — VC Fund, 1 deal together
- [Wellington Partners](https://shizune.co/investors/profile/wellington-partners) — VC Fund, 1 deal together

## About Think.Health

VC Fund · Fürstenfeldbruck, Germany

Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,

4 contacts available at Think.Health.

| Name | Title | Profile |
| --- | --- | --- |
| Dr. Florian Kainzinger | Managing Partner & Founder | https://shizune.co/investors/profile/florian-kainzinger |
| Rob Hamilton | Senior Vice President Of Sales | https://shizune.co/investors/profile/rob-hamilton-7c8d |
| Dr. Michael Ruoff | Partner | https://shizune.co/investors/profile/dr-michael-ruoff |
| Nils Bottler | Venture Partner | https://shizune.co/investors/profile/nils-bottler |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Dr. Florian Kainzinger invest in?

Dr. Florian Kainzinger invests primarily in Medical, Health Care and Biotechnology startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dr. Florian Kainzinger last invest?

The most recent investment recorded for Dr. Florian Kainzinger closed in Aug 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co